已收盤 12-12 16:00:00 美东时间
+0.310
+0.41%
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Barclays analyst Glen Santangelo initiates coverage on Henry Schein (NASDAQ:HSIC) with a Overweight rating and announces Price Target of $86.
12-09 23:57
Capital Group and KKR expand partnership to develop retirement and wealth products combining public and private investments.
12-04 01:12
Biomerica's inFoods® IBS diagnostic-guided therapy demonstrates significant symptom relief in a large, multicenter clinical trial, with 59.6% of patients achieving FDA-defined pain reduction compared to 42.1% in the control group. Particularly effective for IBS-C and IBS-M subtypes, the therapy uses a personalized approach to identify dietary triggers, eliminating only 2-4 foods per patient, offering a practical and sustainable alternative to bro...
11-25 13:19
Henry Schein Inc's (NYSE:HSIC) short interest as a percent of float has fallen ...
11-25 02:00
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
11-15 04:17
Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.
11-12 02:55
KKR & Co. Inc. (NYSE: KKR) plans to launch a tender offer for Japanese company Forum Engineering at a 40.74% premium.
11-10 19:25
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
11-06 20:39
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55